CompletedPhase 2NCT00493129
Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M.D. Anderson Cancer Center
- Principal Investigator
- Srdan Verstovsek, MDM.D. Anderson Cancer Center
- Intervention
- Ontak (Denileukin Diftitox)(drug)
- Enrollment
- 8 enrolled
- Eligibility
- All sexes
- Timeline
- 2004 – 2007
Study locations (1)
- The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00493129 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.